» Articles » PMID: 34843594

Factors Associated with Acceptance of COVID-19 Vaccine Among University Health Sciences Students in Northwest Nigeria

Abstract

Students of the health sciences are the future frontliners to fight pandemics. The students' participation in COVID-19 response varies across countries and are mostly for educational purposes. Understanding the determinants of COVID-19 vaccine acceptability is necessary for a successful vaccination program. This study aimed to investigate the factors associated with COVID-19 vaccine acceptance among health sciences students in Northwest Nigeria. The study was an online self-administered cross-sectional study involving a survey among students of health sciences in some selected universities in Northwest Nigeria. The survey collected pertinent data from the students, including socio-demographic characteristics, risk perception for COVID-19, and willingness to accept the COVID-19 vaccine. Multiple logistic regression was used to determine the predictors of COVID-19 vaccine acceptance. A total of 440 responses with a median (interquartile range) age of 23 (4.0) years were included in the study. The prevalence of COVID-19 vaccine acceptance was 40.0%. Factors that independently predict acceptance of the vaccine were age of 25 years and above (adjusted odds ratio, aOR, 2.72; 95% confidence interval, CI, 1.44-5.16; p = 0.002), instructions from heads of institutions (aOR, 11.71; 95% CI, 5.91-23.20; p<0.001), trust in the government (aOR, 20.52; 95% CI, 8.18-51.51; p<0.001) and willingness to pay for the vaccine (aOR, 7.92; 95% CI, 2.63-23.85; p<0.001). The prevalence of COVID-19 vaccine acceptance among students of health sciences was low. Older age, mandate by heads of the institution, trust in the government and readiness to pay for the vaccine were associated with acceptance of the vaccine. Therefore, stakeholders should prioritize strategies that would maximize the vaccination uptake.

Citing Articles

Prognostic Models of Mortality Following First-Ever Acute Ischemic Stroke: A Population-Based Retrospective Cohort Study.

Mohammed M, Zainal H, Ong S, Tangiisuran B, Aziz F, Sidek N Health Sci Rep. 2025; 8(2):e70445.

PMID: 39957974 PMC: 11825595. DOI: 10.1002/hsr2.70445.


Assessment of COVID-19 Vaccine Knowledge, Uptake, and Factors Influencing its Uptake Among Medical Students at the University of Jos.

Musa I, Kasson K, Musa A, Guda Y, Okoh E Niger Med J. 2025; 65(6):1047-1061.

PMID: 39877507 PMC: 11770665. DOI: 10.60787/nmj.v65i6.555.


Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey.

Ezigbo E, Enitan S, Adejumo E, Durosinmi A, Akele R, Dada M World J Virol. 2024; 13(4):98551.

PMID: 39722760 PMC: 11551692. DOI: 10.5501/wjv.v13.i4.98551.


Predictors for vaccine hesitancy among nursing students in Namibia.

Gabriel R, Kashiva A, Shikesho O J Public Health Afr. 2024; 15(1):683.

PMID: 39649438 PMC: 11622604. DOI: 10.4102/jphia.v15i1.683.


Determinants of COVID-19 vaccine acceptance and hesitancy among adolescents and youths aged 10-35 years in sub-Saharan African countries: A systematic review and meta-analysis.

Mwiinde A, Kaonga P, Jacobs C, Zulu J, Fwemba I PLoS One. 2024; 19(10):e0310827.

PMID: 39374213 PMC: 11458002. DOI: 10.1371/journal.pone.0310827.


References
1.
Riad A, Pokorna A, Antalova N, Krobot M, Zviadadze N, Serdiuk I . Prevalence and Drivers of COVID-19 Vaccine Hesitancy among Czech University Students: National Cross-Sectional Study. Vaccines (Basel). 2021; 9(9). PMC: 8470400. DOI: 10.3390/vaccines9090948. View

2.
Mohammed M, Shaaban A, Jatau A, Yunusa I, Isa A, Wada A . Assessment of COVID-19 Information Overload Among the General Public. J Racial Ethn Health Disparities. 2021; 9(1):184-192. PMC: 7815186. DOI: 10.1007/s40615-020-00942-0. View

3.
Lone S, Ahmad A . COVID-19 pandemic - an African perspective. Emerg Microbes Infect. 2020; 9(1):1300-1308. PMC: 7473237. DOI: 10.1080/22221751.2020.1775132. View

4.
Domek G, OLeary S, Bull S, Bronsert M, Contreras-Roldan I, Bolanos Ventura G . Measuring vaccine hesitancy: Field testing the WHO SAGE Working Group on Vaccine Hesitancy survey tool in Guatemala. Vaccine. 2018; 36(35):5273-5281. PMC: 6145454. DOI: 10.1016/j.vaccine.2018.07.046. View

5.
Afolabi A, Ilesanmi O . Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021; 38:3. PMC: 7825371. DOI: 10.11604/pamj.2021.38.3.27401. View